GlassScriptPhysician profile
Shubha Varma
NPI 1437220795
$905.41
in general payments reported to CMS, 2019-2025
9 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $83.34 · 2021: $123 · 2022: $50.87 · 2023: $303 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $361.58 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Biocompatibles, INC. | $182.29 | 2019 | |
| Organogenesis INC. | $91.27 | 2021-2023 | Puraply |
| Boston Scientific Corporation | $89.08 | 2020-2022 | |
| Resmed Corp | $78.96 | 2023 | |
| Janssen Pharmaceuticals, INC | $55.39 | 2021-2023 | Xarelto |
| Medtronic, INC. | $17.06 | 2021 | |
| Cashflow Solutions, LLC | $15.52 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Pfizer INC. | $14.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shubha Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.